Health Insurance Innovations Inc (NASDAQ:HIIQ) was upgraded by equities research analysts at TheStreet from a “c” rating to a “b-” rating in a research report issued on Monday.

Other equities analysts also recently issued reports about the stock. Raymond James Financial, Inc. raised shares of Health Insurance Innovations from a “market perform” rating to an “outperform” rating and set a $20.00 target price on the stock in a research report on Thursday, May 4th. Zacks Investment Research raised shares of Health Insurance Innovations from a “hold” rating to a “buy” rating and set a $22.00 target price on the stock in a research report on Friday, May 5th. First Analysis assumed coverage on shares of Health Insurance Innovations in a research report on Friday, March 3rd. They set an “overweight” rating on the stock. Canaccord Genuity assumed coverage on shares of Health Insurance Innovations in a research report on Monday, March 13th. They set a “buy” rating and a $28.00 target price on the stock. Finally, Cantor Fitzgerald assumed coverage on shares of Health Insurance Innovations in a research report on Thursday, March 30th. They set an “overweight” rating and a $30.00 target price on the stock. Seven investment analysts have rated the stock with a buy rating, The stock presently has a consensus rating of “Buy” and a consensus price target of $24.00.

Analyst Recommendations for Health Insurance Innovations (NASDAQ:HIIQ)

Shares of Health Insurance Innovations (NASDAQ:HIIQ) traded up 2.63% on Monday, hitting $21.50. The company’s stock had a trading volume of 218,761 shares. Health Insurance Innovations has a 52 week low of $3.72 and a 52 week high of $22.83. The stock has a market capitalization of $254.07 million, a P/E ratio of 19.40 and a beta of 0.67. The stock’s 50 day moving average price is $18.12 and its 200 day moving average price is $16.38.

Health Insurance Innovations (NASDAQ:HIIQ) last posted its earnings results on Wednesday, May 3rd. The financial services provider reported $0.36 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.31 by $0.05. The firm had revenue of $55.87 million for the quarter, compared to the consensus estimate of $54.18 million. Health Insurance Innovations had a net margin of 2.91% and a return on equity of 16.47%. On average, analysts forecast that Health Insurance Innovations will post $1.44 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Health Insurance Innovations Inc (HIIQ) Upgraded at TheStreet” was posted by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://www.americanbankingnews.com/2017/05/25/health-insurance-innovations-inc-hiiq-upgraded-at-thestreet.html.

In other Health Insurance Innovations news, insider Sheldon Wang sold 7,560 shares of the company’s stock in a transaction dated Wednesday, March 15th. The shares were sold at an average price of $16.77, for a total transaction of $126,781.20. Following the completion of the sale, the insider now directly owns 250,001 shares in the company, valued at $4,192,516.77. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Bruce Telkamp sold 18,745 shares of the company’s stock in a transaction dated Friday, May 12th. The shares were sold at an average price of $21.94, for a total transaction of $411,265.30. Following the sale, the chief executive officer now owns 107,211 shares of the company’s stock, valued at $2,352,209.34. The disclosure for this sale can be found here. Insiders have sold 3,161,901 shares of company stock valued at $42,504,453 over the last 90 days. Corporate insiders own 52.70% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in the stock. Bank of Montreal Can purchased a new stake in Health Insurance Innovations during the first quarter worth about $118,000. Royal Bank of Canada purchased a new stake in Health Insurance Innovations during the second quarter worth about $127,000. Acrospire Investment Management LLC boosted its stake in Health Insurance Innovations by 36.8% in the first quarter. Acrospire Investment Management LLC now owns 11,505 shares of the financial services provider’s stock worth $184,000 after buying an additional 3,094 shares during the period. Bank of New York Mellon Corp boosted its stake in Health Insurance Innovations by 11.5% in the first quarter. Bank of New York Mellon Corp now owns 12,270 shares of the financial services provider’s stock worth $197,000 after buying an additional 1,266 shares during the period. Finally, Prescott Group Capital Management L.L.C. purchased a new stake in Health Insurance Innovations during the second quarter worth about $219,000. Institutional investors own 23.18% of the company’s stock.

About Health Insurance Innovations

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

12 Month Chart for NASDAQ:HIIQ

Receive News & Ratings for Health Insurance Innovations Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc and related companies with MarketBeat.com's FREE daily email newsletter.